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Prostaglandin E, (PGE,) and platelet activation factor (PAF) were found respectively to activate or to in- 
hibit cholesterol esterification in whole plasma but not in lipoprotein-deficient plasma. It is suggested that 
these effects are mediated by the interaction of PGE, and PAF with high-density lipoproteins [(1984) FEBS 
Lett. 173,291-2941. Possible physiological implications of these findings are discussed. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Investigations carried out in these laboratories 
using phospholipid fluorescence probes dem- 
onstrated that low amounts of PAF and PGEi 
caused oppositely directed changes in the surface 
structure of HDL [ 1,2]. Analysis of the binding of 
PAF to various lipoprotein classes revealed that 
PAF binds unspecifically to very low density 
lipoproteins whereas HDL exhibit high affinity for 
PAF binding sites [3]. The existence of specific 
PAF binding sites on and the reorganization of the 
HDL surface caused by PAF and PGEl indicate 
that both these lipid effecters could influence the 
physiological functions of HDL. Since an impor- 
tant function of HDL is to serve as substrate and 
activator of LCAT, we investigated the influence 
of PAF and various PCs on the esterification of 
cholesterol in human plasma. The results 
demonstrate that PAF inhibits and PGEl activates 
plasma cholesterol esterification in the presence of 
lipoproteins but not in lipoprotein-deficient 
plasma. Some possible physiological implications 
of these findings are discussed. 
lcu,2CY-[3H]Cholesterol (43 Ci/mmol) was pur- 
chased from Amersham (England). Prostaglandins 
El, Ez, Fh, cholesterol and cholesteryl oleate were 
obtained from Serva (FRG). 
1-0-Alkyl-2-0-acetyl-sn-glycero-3-phosphocho- 
line was obtained by acylation of alkyllysophos- 
phatidylcholine with acetic anhydride according to 
[41. 
Human blood plasma (blood group O(1) or 
AB(IV) was prepared by centrifugation (5000 rpm, 
15 min) of platelet-rich plasma. 
Cholesterol esterification assays were carried out 
by incubation of [3H]cholesterol (5-10 /rCi/ml) 
with plasma at 37°C. [3H]Cholesterol ester forma- 
tion was determined by thin-layer chromatography 
of the lipid extracts on F 254 silica gel plates 
(Merck) with petroleum ether-diethyl ether-acetic 
acid (90: 10: 1, v/v) as developing solvent and 
measurement of the radioactivity of the cholesterol 
ester fraction. 
Abbreviations: PAF, platelet activation factor, 
l-alkyl-2-acetyl-sn-glycero-3-phosphocholine; PG, 
prostaglandin; HDL, high-density lipoproteins; LCAT, 
lecithin : cholesterol-acyltransferase 
Lipoprotein-free plasma was obtained by 
precipitation of lipoproteins with phosphotungstic 
acid and MnClz [5]. After centrifugation 
lipoprotein-free plasma was dialyzed against Na- 
citrate buffer, pH 7.4. 
Liposomes prepared by brief sonication were 
composed of phosphatidylcholine and cholesterol 
in a molar ratio 7 : 2. 
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LCAT activity of lipoprotein free plasma was 
determined by measurement of [3H]cholesterol 
ester formation after incubation of lipoprotein- 
free plasma (0.3 ml) and liposomes (3.23 PM 
[3H]cholesterol) at 37°C for l-2 h. 
3. RESULTS AND DISCUSSION 
Fig.1 shows that preincubation of plasma with 
small amounts of PAF (10-‘“-10-8 M) results in 
significant inhibition of esterification, whereas 
PGEi in the same concentration range enhances 
the reaction. When the two compounds were ap- 
plied in the same concentration (10V9 M) the 
stimulating effect of PGEi was stronger than the 
inhibiting effect of PAF. In the presence of both 
PAF (10e9 M) and PGEt (lo-’ M) the esterifica- 
tion reaction was inhibited to the same extent as 
with PAF alone (not shown). Thus, there is no 
competition between PGEi and PAF. Never- 
theless, the effect of PGEi is highly specific: as can 
be seen from fig. 1 PGEz in the same concentration 
range (lo-” - 1 O-’ M) caused only insignificant ac- 
tivation, whereas PGFh was completely ineffec- 
tive. It should also be noted that in contrast to 
PAF and PGEi, the effect of PGEz was concentra- 
tion independent and thus probably nonspecific. 
In principle, the influence of PAF or PGEi on 
the esterification of cholesterol could be attributed 
to direct interaction of these substances with 
LCAT or to their influence on the HDL structure. 
To solve this question esterification experiments 
were carried out with lipoprotein-deficient plasma 
using egg phosphatidylcholine-cholesterol lipo- 
A 
/ 
0 El 
7- 
5 0-0 Ez 
E 
a a 
v 
A FP. 
x PAF 
OL 
10-10 O9 10-e 
Fig.1. Influence of PAF and prostaglandins Er, Ez and 
F& on the esterification of cholesterol in human plasma. 
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Fig.2. Influence of PGEr and PAF on the esterification 
of cholesterol in lipoprotein deficient plasma. 
somes as substrates for LCAT. As can be seen 
from fig.2 under such conditions neither PAF nor 
PGEi had any effect on the cholesterol esterifica- 
tion. It follows that the influence of PAF and 
PGEi on the plasma cholesterol esterification is 
mediated by their interaction with plasma lipopro- 
teins, most probably HDL. In any case the results 
of this work demonstrate unequivocally that PAF 
and PGEi oppositely shift the balance between free 
and esterified cholesterol in plasma. This fact 
could be one of the possible causes of the opposite 
effects of PAF and PGEi on platelet aggregation. 
Human platelets have been shown not to be able to 
synthesize cholesterol de novo [6], and at the same 
time to be sensitive to the plasma level of free 
cholesterol: increase in plasma free cholesterol is 
known to result in formation of hypersensitive, 
more readily aggregating platelets [7]. Thus PAF 
and PGEi could enhance or inhibit platelet ag- 
gregation by respectively inhibiting or enhancing 
cholesterol esterification. Experiments designed to 
check this hypothesis are in progress. 
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